Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

Research is quickly catching up. In the last few years, studies have linked GLP-1 drugs like Ozempic and Wegovy with fewer ...

Since weight-loss drugs that target the hormone GLP-1 have surged in popularity, some additional health benefits have emerged. Beyond helping people shed pounds, they also lower the risk of heart ...

The effect was seen across a wide variety of addictive and habit-forming substances, including cocaine, opioids, alcohol, ...

My team and I set out to test whether GLP-1 drugs — medications like semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound), originally developed for diabetes and then approved for ...

A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.

Semaglutide, the active ingredient behind blockbuster weight-loss drugs like Wegovy, is now at the center of a growing body of evidence suggesting it can sharply reduce alcohol consumption in people ...

Local nonprofit, Healing Transitions, is currently helping more than 450 people with drug and alcohol recovery. With the help of the newest housing facility, leaders believe it will fill the most ...

When Passerose Mantoy first started working in addiction services in Dublin in 2000, the city was at the back end of the ...